Bioengineering and Life Sciences Initiative (BELS)

Only 8% of the more than 10,000 diseases affecting humans worldwide have a FDA-approved treatment. To foster radical collaboration and accelerate progress toward finding disease treatments, the Notre Dame Bioengineering and Life Science Initiative (BELS) will serve as an intellectual hub for scientific discovery and disease solutions.